(688710)"SHANGHAI INNOSTAR BIO-TECH CO., LTD."Report for Q3 2026
Filed with SSE · Stock code 688710 · · 13 pages · Chinese
Summary by 6ix AI
Shanghai Innostar Bio-tech Co. Ltd. has released its third quarter report for the year, detailing key financial data and shareholder information. It also discusses the company's commitment to maintaining compliance with global standards in drug development and research. The financial statements included in the report are unaudited and cover the period from the beginning of the year to the end of September.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Shanghai InnoStar Bio-tech Co. Ltd. on 6ix
Earlier from Shanghai InnoStar Bio-tech
- (688710)"SHANGHAI INNOSTAR BIO-TECH CO., LTD."Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
- Announcement on Listing and Trading of Shares for Strategic Allotment in Initial Public Offering
- Announcement on Re-appointment of Accounting Firm
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Reply to Letter of Supervision and Inquiry on Information Disclosure of 2025 Annual Report
Later from Shanghai InnoStar Bio-tech
All Shanghai InnoStar Bio-tech news releasesFollow Shanghai InnoStar Bio-tech into a list and get an email when it puts out news.
Follow Shanghai InnoStar Bio-tech